J Clin Endocrinol Metab 109(1):49 Neves JS, Vasques-Nvoa F, Borges-Canha M, Leite AR, Sharma A, Carvalho D, Packer M, Zannad F, Leite-Moreira A, Ferreira JP (2023) Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: a post hoc analysis of the FIGHT trial
Hesperidin supplementation also led to a 33% reduction in median levels of the inflammatory marker high-sensitivity C-reactive protein (hs-CRP), as well as significant decreases in levels of total cholesterol, apolipoprotein B (apoB), and markers of vascular inflammation, relative to placebo (Rizza 2011)
But that may be because those previous studies included a higher proportion of people who were prescribed GLP-1s for diabetes, while the new study skewed toward people who specifically took the medicines for obesity
The residues in a contact with heme in the active center are shown to be different for protoheme and heme d enzymes
ESR, erythrocyte sedimentation rate